The medications available now have substantial trial evidence, established safety profiles, and known cost paths
A larger share, 60% , cover GLP-1s for diabetes only, and 45% cover them for other FDA-approved conditions such as sleep apnea and cardiovascular disease
The approval came in just 54 days under the FDA's Commissioner's National Priority Voucher (CNPV) pilot program
Based on your unique metabolic profile, Dr
The body maintains a defended weight through complex hormonal and neural mechanisms that developed over millions of years of evolution when food scarcity posed a real survival threat
Theres been a rise of what I call marketing bros getting into the space. These operators see an opportunity for profit but have no background or interest in the medicine or customer experience, she says